US Patent

US7598276 — Pharmaceutical salts and polymorphs of a factor Xa inhibitor

Composition of Matter · Assigned to Millennium Pharmaceuticals Inc · Expires 2026-11-08 · 0y remaining

Vulnerability score 22/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects salts of a compound that inhibits mammalian factor Xa, along with methods of making that compound.

USPTO Abstract

The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making the compound of Formula I.

Drugs covered by this patent

Patent Metadata

Patent number
US7598276
Jurisdiction
US
Classification
Composition of Matter
Expires
2026-11-08
Drug substance claim
Yes
Drug product claim
No
Assignee
Millennium Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.